Details for Patent: 6,066,616
✉ Email this page to a colleague
Title: | Somatostatin analogue composition and use in treating breast cancer |
Abstract: | The invention provides a pharmaceutical composition comprising a somatostatin analogue, and its use in the treatment of breast cancer. The pharmaceutical composition preferably contains lactic acid in addition to the somatostatin analogue and is better tolerated when administered by injection. |
Inventor(s): | Cavanak; Thomas (Biel-Benken, CH), Harris; Alan (Basel, CH) |
Assignee: | Novartis AG (Basel, CH) |
Filing Date: | Feb 11, 1998 |
Application Number: | 09/022,079 |
Claims: | 1. A method of treating breast cancer in a subject which comprises administering a therapeutically effective amount of octreotide or octreotide as a pharmaceutically acceptable salt to a subject in need of such treatment. 2. A method of claim 1 in which the octreotide is co-administered with a dopamine agonist. |